All resources
Research

Accuracy of three commercial wearable devices for sleep tracking in healthy adults

Description

This independent validation study from Brigham and Women’s Hospital and Harvard Medical School evaluated the sleep tracking accuracy of three consumer devices against gold-standard polysomnography (PSG). Monitoring 35 healthy adults during a single-night inpatient tracking trial, researchers analyzed epoch-by-epoch performance metrics for sleep-wake states and specific sleep stages.

While all tested hardware demonstrated 95% or greater sensitivity for identifying sleep, tracking accuracy for individual stages varied significantly across brands. The findings revealed that Oura Ring Gen3 demonstrated substantial agreement with PSG, performing as the only device with no statistically significant variance from the gold standard in estimating wake, light sleep, deep sleep, and REM sleep durations.

Expert perspective

“The Oura Ring exhibited substantial agreement in the determination of specific sleep stages (Kappa > 0.61).”


Notes

*Currently not available through the John Hancock Vitality Program in Guam, Puerto Rico, New Mexico, North Dakota, New York, and Vermont.

Vitality is the provider of the John Hancock Vitality Program in connection with policies issued by John Hancock. John Hancock Vitality Program rewards and discounts are available only to the person insured under the eligible life insurance policy, may vary based on the type of insurance policy purchased and the state where the policy was issued, are subject to change and are not guaranteed to remain the same for the life of the policy. John Hancock insurance products are issued by: John Hancock Life Insurance Company (U.S.A.), Boston, MA 02116 (not licensed in New York) and John Hancock Life Insurance Company of New York, Valhalla, NY 10595. MLINY051023599-1


Could your organization benefit from Oura?

Let’s discuss your needs and discover how Oura can help you.

Contact us